Outcomes in patients with newly diagnosed TP53‐mutated acute myeloid leukemia with or without venetoclax‐based therapy
暂无分享，去创建一个
M. Konopleva | M. Andreeff | H. Kantarjian | G. Garcia-Manero | E. Shpall | T. Kadia | F. Ravandi | G. Borthakur | N. Daver | C. Dinardo | R. Kanagal-Shamanna | U. Popat | N. Pemmaraju | N. Short | S. Pierce | K. Sasaki | G. Montalban-Bravo | Mahran Shoukier | S. Venugopal | K. Marx